Document is current
Any future updates will be listed below
-
Authors
Schlepckow, Kai
Kleinberger, Gernot https://orcid.org/0000-0002-5811-8226
Fukumori, Akio
Feederle, Regina
Lichtenthaler, Stefan F
Steiner, Harald https://orcid.org/0000-0003-3935-0318
Haass, Christian https://orcid.org/0000-0002-4869-1627
-
Funding
Funding for this research was provided by:
Cure Alzheimer's Fund
Horizon 2020 ‐ Research and Innovation Framework Programme (115976)
Deutsche Forschungsgemeinschaft (EXC 1010 SyNergy)
Deutsche Forschungsgemeinschaft (FOR 2290)
- License Information
-
More Information
Article History
Received: 7 February 2017
Revised: 26 June 2017
Accepted: 14 July 2017
First Online: 30 August 2017
Conflict of interest
: C.H. is an advisor of F. Hoffmann‐La Roche. C.H., G.K, and K.S. filed a patent (EP16180844) for the use of TREM2 cleavage modulators.
